A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|5|8|418-426

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.5, Iss.8, 2016-08, pp. : 418-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ursodeoxycholic acid in primary biliary cirrhosis improves glutathione status but fails to reduce lipid peroxidation

By Pemberton Philip W.   Aboutwerat Ali   Smith Alexander   Warnes Thomas W.  

Redox Report, Vol. 11, Iss. 3, 2006-06 ,pp. : 117-123

Maney Publishing

Access to resources Recommend Favorite

Effect of Ursodeoxycholic Acid Administration in Patients with Primary Hypercholesterolaemia

By Cicognani C.   Malavolti M.   Morselli-Labate A.M.   Talarico R.   Zamboni L.   Sama C.  

Clinical Drug Investigation, Vol. 18, Iss. 4, 1999-10 ,pp. : 263-269

Adis International

Access to resources Recommend Favorite

Addison's other disease: primary biliary cirrhosis as a model autoimmune disease

By Jones David E J  

Clinical Medicine, Vol. 3, Iss. 4, 2003-07 ,pp. : 351-356

Royal College Of Physicians

Access to resources Recommend Favorite

Options for Treatment of Primary Biliary Cirrhosis

By Ye H. Oo   James Neuberger  

Drugs, Vol. 64, Iss. 20, 2004-01 ,pp. : 2261-2271

Adis International

Access to resources Recommend Favorite

Reviewing therapies for primary biliary cirrhosis

By  

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite